Gotistobart Clinical Trials

1 actively recruiting trial across 1 location

Also known as: A humanized anti-CTLA4 IgG1 monoclonal antibody, BNT316, ONC-392

Filter by location:

Dothan, Alabama1 trial

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

XCancer/Dothan Hematology & Oncology - 1114

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.